DePuy fracture program could help ease CMS pains

Newly proposed Centers for Medicare & Medicaid (CMS) programs could be made a bit easier to deal with thanks to Johnson & Johnson Medical Devices Companies. DePuy Synthes’ Geriatric Fracture Program could help hospitals work through the proposed mandatory coordinated care/episode payment programs.

The CMS proposal--which was filed in the Federal Register on August 2--would compensate care providers for an “episode” of care rather than individual care components. The episode would include the inpatient stay and 90 days after discharge. Treatments for surgical hip/femur fracture treatment, acute myocardial infarction and coronary artery bypass graft are included in the proposal.


Join the world's top medtech executives virtually for the leading event in medtech — The Virtual MedTech Conference by AdvaMed

Expect the same high-quality education, world-class speakers and valuable business development in a virtual format. Experience more of the conference with on demand content and partnering, as well as livestreamed sessions.

"The CMS proposal accelerates the drive toward a more integrated, value-based health care system in the US," said Tim Schmid, chief strategic customer officer at Johnson & Johnson Medical Devices Companies, in a statement. "By its very design, the Geriatric Fracture Program significantly elevates the ability of hospitals to meet the goals of the Triple Aim by improving patient outcomes, reducing costs and enhancing the patient experience.”

In addition to the Geriatric Fracture Program, Johnson & Johnson offers a suite of programs aimed at “operational integration and efficiency, continuum of care, and patient engagement and experience,” Johnson & Johnson explained in the announcement.

The Geriatric Fracture Program specifically has four components that would “complement” the proposed CMS program. This includes assessing whether a facility is ready to implement the program, support during implementation, materials assisting in implementation and a performance dashboard that would help to collect data and metrics.

According to Johnson & Johnson, the Geriatric Fracture Program has helped to address morbidity, mortality and cost. Studies have found “reductions in length of stay, post-operative delirium, and in-hospital post-operative falls,” the company explained in the announcement.

- here's the press release
- and here's the CMS's filing

Related Articles:
J&J's DePuy comes under fire for all-metal hip manufacturing in U.K.
J&J's DePuy buys shape-changing, minimally invasive small bone fixation tech startup
J&J Depuy does a pair of deals, one to treat disc degeneration and another for bundled payments

Suggested Articles

Spinal Elements, maker of a wide range of implants and products for minimally invasive spine procedures, has filed a $100 million IPO.

United Airlines will begin providing COVID-19 screening tests for passengers, allowing those who test negative to skip local quarantine requirements.

Galecto picked up $64 million to push its lead lung disease treatment toward an approval in Europe and fund midstage studies for its other programs.